Samphire Neuroscience
medical-grade neurostimulation wearable
Samphire Neuroscience has raised €6.5M across 2 funding rounds from 10 investors, most recently a Series A round in Jun 2025. Based in London, UK; active in Healthtech. Data as of 4 Nov 2026.
London, UKsamphireneuro.com ↗
Total raised
€6.5M
€6,491,358
Funding rounds
2
Investors
10
distinct backers
Active since
2024-02
latest 2025-06
Funding by year
EUR raised per yearSamphire Neuroscience — funding by year — interactive chart.
Data table
| Samphire Neuroscience — funding by year | |
|---|---|
| 2024 | €2.1M |
| 2025 | €4.4M |
Signals
High confidenceRaise-next likelihood71
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-03 | Series A | €4.4M | Fortify Ventures,Inventure | View deal → |
| 2024-02-21 | Pre-Seed | €2.1M | Afterwork,Ayuh,CVX Ventures,Dr Pamela Walker,FIRSTPICK,Russell Buckley+2 more | View deal → |
Investors
10Similar companies
same sector, similar size- Healthera€5.7MUK · Healthtech
- MediShout€8.8MUK · Healthtech
- PolyModels Hub€9.2MUK · Healthtech
- Abselion€8.0MUK · Healthtech
- Oxford Endovascular€9.4MUK · Healthtech
- EnsiliTech€6.6MUK · Healthtech
Global coverage: FundingData